Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma

Clinical trial NCT00109863 · COMPLETED

Trial details

NCT number: NCT00109863
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2005-05-01
Primary completion: 2007-07-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.